Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Austin Doyle
L. Austin Doyle
University of Pittsburgh
Medicine
Pathology
Proto-Oncogene Proteins B-raf
Protein kinase B
Clinical endpoint
3
Papers
425
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
2011
Journal of Clinical Oncology
Tanios Bekaii-Saab
Mitch A. Phelps
Xiaobai Li
Motoyasu Saji
Laura Williams Goff
John Kauh
Bert H. O’Neil
Stephanie M. Balsom
Catherine Balint
Ryan Liersemann
Vasily Vasko
Mark Bloomston
William L. Marsh
L. Austin Doyle
Gilian Ellison
Michael R. Grever
Matthew D. Ringel
Miguel A. Villalona-Calero
Show All
Source
Cite
Save
Citations (234)
Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
2010
Journal of Clinical Oncology
Sonali M. Smith
Koen van Besien
Theodore Karrison
Janet Dancey
Peter McLaughlin
Anas Younes
Scott E. Smith
Patrick J. Stiff
Eric P. Lester
Sanjiv Modi
L. Austin Doyle
Everett E. Vokes
Barbara Pro
Show All
Source
Cite
Save
Citations (163)
Pharmacokinetic and Pharmacodynamic Study of the Combination of Docetaxel and Topotecan in Patients With Solid Tumors
2000
Journal of Clinical Oncology
William C. Zamboni
Merrill J. Egorin
David A.V. Van Echo
Roger Day
Barry R.M. Meisenberg
Sandra Elane Brooks
L. Austin Doyle
Noble N. Nemieboka
Jason M. Dobson
Nancy S. Tait
Katherine H. Tkaczuk
Show All
Source
Cite
Save
Citations (28)
1